ZITUVIMET
Live / Registered — Registered (as of 27 May 2025)
What this means for you
Registered since 27 May 2025. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 27 May 2031: the §8 declaration of use).
Record
- Serial number
- 97690293
- Registration number
- 7811977
- Mark type
- Word mark
- Filed
- 23 Nov 2022
- Published for opposition
- 04 Apr 2023
- Registered
- 27 May 2025
- Next maintenance filing
- §8 declaration of use, due by 27 May 2031 (grace period to 27 Nov 2031)
- Attorney of record
- Anthony J. DiMarino
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for treating diabetes
Owner
- Zydus Pharmaceuticals (USA) Inc., Pennington, NJ, US
- Zydus Pharmaceuticals (USA) Inc., Pennington, NJ, US
- Zydus Pharmaceuticals (USA) Inc., Pennington, NJ, US
Prosecution history
- 27 May 2025 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 27 May 2025 — REGISTERED-PRINCIPAL REGISTER
- 07 May 2025 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 07 May 2025 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 07 May 2025 — STATEMENT OF USE PROCESSING COMPLETE
- 30 Apr 2025 — USE AMENDMENT FILED
- 01 May 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 30 Apr 2025 — TEAS STATEMENT OF USE RECEIVED
- 30 Apr 2025 — SOU EXTENSION 4 GRANTED
- 30 Apr 2025 — SOU EXTENSION 4 FILED
- 30 Apr 2025 — SOU TEAS EXTENSION RECEIVED
- 03 Feb 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 02 Feb 2025 — SOU EXTENSION 3 GRANTED
- 18 Nov 2024 — SOU EXTENSION 3 FILED
- 02 Feb 2025 — CASE ASSIGNED TO INTENT TO USE PARALEGAL